The “Immunoscore” is based on immune densities of two lymphocyte populations (CD3+ and CD8+ T cells) that infiltrate the core of the tumor (CT) and invasive margin (IM) as quantified by immunohistochemistry (IHC). Here, CD8A is linked to neoplasm.